№ files_lp_4_process_3_133482
File format: docx
Character count: 2087
File size: 544 KB
Announcement detailing free rapid testing for HIV, syphilis, and hepatitis C at Walgreens locations nationwide, including information about the participating organizations, testing methods, and support services.
Year:
2026
Location:
United States, including Washington, D.C., and Puerto Rico
Topic:
Public Health / Infectious Diseases
Document Type:
Public Announcement / Press Release
Organization:
Walgreens; KFF’s Greater Than HIV/STDs Initiative
Audience:
General public, individuals at risk of HIV, syphilis, or hepatitis C
Event Date:
June 27, 2026
Testing Services:
HIV, syphilis, hepatitis C
Participation:
Over 415 health departments and community organizations, 575 Walgreens stores
Testing Method:
Rapid finger stick or oral swab, results in 20 minutes
Support Services:
Counseling, referrals, information on prevention and treatment
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / City:
Massachusetts
Subject:
Pharmacy Regulation
Document Type:
Consent Agreement
Organization / Institution:
Massachusetts Board of Registration in Pharmacy
Author:
Massachusetts Board of Registration in Pharmacy
Target Audience:
Pharmacy Licensees
Period of Action:
From 3/26/2021
Approval Date:
3/26/2021
Amendment Date:
None
Year:
2025
Region / City:
Victoria, Australia
Topic:
Syphilis diagnosis, management, and prevention
Document type:
Clinical guideline
Organization / Institution:
Department of Health, Victoria
Author:
Department of Health, Victoria
Target audience:
Healthcare professionals, clinicians
Effective period:
February 2025
Date of approval:
February 2025
Date of changes:
February 2025
Year:
2025
Region / City:
Victoria, Australia
Topic:
Health / Pregnancy
Document Type:
Informational brochure
Organization:
Victorian Government, Department of Health
Author:
Victorian Government, Department of Health
Target Audience:
Pregnant women and their partners
Effective Period:
2025
Approval Date:
January 2025
Date of Changes:
Not specified
Year:
2021
Region / City:
Western Australia
Subject:
Antenatal healthcare, Syphilis treatment
Document type:
Policy / Procedure
Organization:
WA Health
Author:
Dr Andrew Robertson
Target audience:
Midwives working in antenatal healthcare programs
Period of validity:
From August 2021
Approval date:
19 August 2021
Modification date:
Not specified
Issued by:
Chief Health Officer
Conditions of use:
In accordance with Medicines and Poisons Regulations 2016
Approved medicines:
Benzathine benzylpenicillin 1.8 grams
Approved activity:
Administration of a single dose
Medical conditions:
Syphilis infection in adults and mature minors (14+), with confirmed or symptomatic cases
Training:
Approved training required for midwives administering medication
Notification:
Syphilis diagnosis must be notified to the Department of Health within 24 hours
Conditions for administration:
Adherence to "Silver Book" guidelines, record keeping, procurement, and storage regulations
Topic:
Medical ethics and human experimentation
Type of document:
Analytical summary
Subject:
Tuskegee Syphilis Study
Country:
United States
Institution involved:
United States Public Health Service
Population described:
African American men aged 25–50
Medical condition:
Syphilis
Key medical treatment referenced:
Penicillin
Historical context:
World War II
Ethical issue:
Deception and lack of informed consent in medical research
Year:
2020
Region / City:
Not specified
Theme:
Communication Competency, Thinking Competency, Personal & Social Competency
Document Type:
Self-Reflection
Author:
Morgan Oliver
Target Audience:
Students, Educators
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2017
Country:
Australia
Topic:
Syphilis in pregnancy
Document type:
Evidence evaluation report
Prepared by:
Ampersand Health Science Writing
Commissioned by:
Australian Government Department of Health
Target population:
Pregnant women, including Aboriginal, Torres Strait Islander, migrant, and refugee women
Review scope:
Prevalence, testing, interventions, and additional considerations
Period covered:
Studies up to 2017
Methodology:
Systematic review and evidence grading using NHMRC criteria
Key outcomes:
Congenital syphilis, perinatal mortality, testing uptake, treatment effectiveness, cost-effectiveness
Included studies:
35 studies reviewed
Note:
Year
Subject:
Viral Hepatitis
Document Type:
Health Department Report
Organization:
Kansas Health Department
Target Audience:
Healthcare providers
Year:
2025
Region / City:
United Kingdom
Subject:
Viral Hepatitis Management
Document Type:
Clinical Guideline
Author:
Lucy Garvey, Sanjay Bhagani, Ranjababu Kulasegaram, Michael Butler, Emma Hathorn, Paul Randal, Sarah Smith, Ryan White, Rachel Halford, Alison Grant, Giovanni Villa, Subathira Dakshina, Sema Mandal, Dan Bradshaw
Target Audience:
Healthcare professionals in sexual health and infectious diseases
Period of Validity:
2025
Approval Date:
July 21, 2025
Version:
1.2
Version Date:
July 21, 2025
Year:
2025
Region:
England
Subject:
Hepatitis B vaccination for renal patients
Document Type:
Patient Group Direction (PGD)
Authorising Organisation:
UK Health Security Agency (UKHSA)
Target Audience:
Registered healthcare professionals
Period of Validity:
28 February 2025 - 28 February 2028
Approval Date:
28 February 2025
Amendment Date:
21 February 2025
Note:
Year
Topic:
Hepatitis B Virus
Document Type:
Agent Summary
Organization / Institution:
U.S. Department of Health and Human Services, CDC, NIH
Target Audience:
Laboratory personnel, researchers
Description:
This document provides a detailed summary of the Hepatitis B virus, its characteristics, risks, transmission, diagnosis, and biosafety precautions for laboratory handling.
Year:
2018
Region / city:
Australia
Topic:
Immunisation, Hepatitis B
Document type:
Report
Agency / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Chief Medical Officer
Target audience:
Healthcare professionals, policymakers
Period of validity:
Until 31 December 2019
Date of approval:
June 2018
Date of amendments:
None
Year:
2003
Region / city:
United States
Topic:
Hepatitis C, Clinical Reports, VISTA System
Document Type:
User Manual
Organization / Institution:
Department of Veterans Affairs
Author:
Not specified
Target Audience:
Local Coordinators, Managers, Clinicians
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Context:
This user manual provides instructions for using the CPRS Query Tool for generating Hepatitis C-related clinical reports within the VISTA system.
Year:
2024
Region / city:
Australia
Theme:
Hepatitis B, Vaccination, Disease Surveillance
Document type:
Epidemiological review
Organ / institution:
Australian Government Department of Health
Authors:
Nicole Sonneveld, Joanne Jackson, Aditi Dey, Stephen Lambert, Katrina Clark, Benjamin Cowie, Kristine Macartney, Frank Beard
Target audience:
Researchers, health professionals, policymakers
Period of action:
2000–2019
Approval date:
24/06/2024
Date of changes:
N/A
Year:
2023
Region / city:
Not specified
Topic:
Hepatitis B, Hepatitis C, Public health
Document type:
Data collection form
Organization / institution:
Centers for Disease Control and Prevention (CDC)
Author:
Not specified
Target audience:
Healthcare professionals, Public health departments
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Contextual description:
A form used to gather clinical and diagnostic data from patients with recent hepatitis B or C infections, without known risk factors, to assess potential healthcare exposure windows for further public health investigation.
Year:
2024
Region / City:
UK
Topic:
Hepatitis A, Public Health Surveillance
Document Type:
Questionnaire
Organization:
UKHSA
Authors:
Maya Gobin, Koye Balogun, Obaghe Edeghere
Target Audience:
Public Health Professionals, Healthcare Workers
Effective Period:
2024 - ongoing
Approval Date:
March 2024
Review Date:
April 2024
Version:
1.2
Last Modified:
March 2024
Year:
2023
Region / city:
England
Subject:
Vaccination, Hepatitis A
Document type:
Patient Group Direction (PGD)
Organization / institution:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Dr. Sema Mandal, David Green
Target audience:
Healthcare practitioners
Period of validity:
31 October 2023 - 31 October 2026
Approval date:
5 October 2023
Review date:
31 March 2026
Expiry date:
31 October 2026
Version:
V5.00
Changes history:
Updated with new vaccine licensed for children, changes to vaccine administration routes
Description:
A PGD for the administration of the Hepatitis A vaccine to individuals at high risk, developed and authorised by UKHSA.
Year:
2015
Region / city:
Australia, New Zealand
Topic:
Hepatitis A virus inactivation in berries
Document type:
Guideline
Organization:
Food Standards Australia New Zealand, Ministry for Primary Industries
Author:
FSANZ Risk Assessment (Microbiology), Ministry for Primary Industries
Target audience:
Food manufacturers, food safety professionals
Period of validity:
Not specified
Approval date:
December 2015
Date of changes:
Not specified
Year:
2013
Region / City:
North Central
Topic:
Hepatitis B vaccination
Document Type:
Informed consent form
Organization:
North Central Health Care
Author:
N/A
Target Audience:
Employees at risk of Hepatitis B exposure
Period of validity:
N/A
Approval Date:
N/A
Amendment Date:
N/A